ORTX - Orchard Therapeutics PLC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ORTX is currently covered by 4 analysts with an average price target of $67.4. This is a potential upside of $50.7 (303.59%) from yesterday's end of day stock price of $16.7.

Orchard Therapeutics PLC's activity chart (see below) currently has 27 price targets and 31 ratings on display. The stock rating distribution of ORTX is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.77% with an average time for these price targets to be met of 102.46 days.

Highest price target for ORTX is $16, Lowest price target is $5, average price target is $67.4.

Most recent stock forecast was given by DAE GON HA from STIFEL on 05-Oct-2023. First documented stock forecast 26-Nov-2018.

Currently out of the existing stock ratings of ORTX, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$16

$-0.7 (-4.19%)

$22

1 years 2 months 20 days ago
(05-Oct-2023)

1/2 (50%)

$0.05 (0.31%)

1

Buy

$15

$-1.7 (-10.18%)

$15

1 years 5 months 28 days ago
(27-Jun-2023)

2/2 (100%)

$9.77 (186.81%)

146

Buy

1 years 6 months 12 days ago
(13-Jun-2023)

1/2 (50%)

$88 (107.32%)

428

Buy

$5

$-11.7 (-70.06%)

1 years 9 months 12 days ago
(13-Mar-2023)

1/1 (100%)

$0.05 (1.01%)

1

Buy

$13

2 years 7 months 12 days ago
(13-May-2022)

1/2 (50%)

$-34.2 (-72.46%)

481

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ORTX (Orchard Therapeutics PLC) average time for price targets to be met?

On average it took 102.46 days on average for the stock forecasts to be realized with a an average price target met ratio 30.77

Which analyst has the current highest performing score on ORTX (Orchard Therapeutics PLC) with a proven track record?

PETE STAVROPOULOS

Which analyst has the most public recommendations on ORTX (Orchard Therapeutics PLC)?

Pete Stavropoulos works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on ORTX

Which analyst is the currently most bullish on ORTX (Orchard Therapeutics PLC)?

Emma Nealon with highest potential upside - $112.27

Which analyst is the currently most reserved on ORTX (Orchard Therapeutics PLC)?

Hartaj Singh with lowest potential downside - -$11.7

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?